Heterocyclic compounds based on N6-substituted adenine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41210%2F04%3A6688" target="_blank" >RIV/60460709:41210/04:6688 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Heterocyclic compounds based on N6-substituted adenine
Original language description
Invention is concerned on new substitutive derivatives N6-benzyladenosine, která with anticarcenogenic, mitotic, imunosupressive and antisenescent effects for plant, animal and human cells. Methods of synthesis, pharmaceutic composition of thiese medicals, its pharmaceutical composition, the preparation of active substanceswith practical usage in a biotechnology, cosmetic industry and in agriculture are debated
Czech name
Heterocyklické substituční deriváty N6-benzyladenosinu
Czech description
Invention is concerned on new substitutive derivatives N6-benzyladenosine, která with anticarcenogenic, mitotic, imunosupressive and antisenescent effects for plant, animal and human cells. Methods of synthesis, pharmaceutic composition of thiese medicals, its pharmaceutical composition, the preparation of active substanceswith practical usage in a biotechnology, cosmetic industry and in agriculture are debated
Classification
Type
P - Patent
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2004
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
PCT/CZ03/00078
Publisher
—
Publisher name
—
Place of publication
—
Publication country
—
Date of acceptance
Jan 10, 2004
Owner name
DOLEŽAL KAREL A SPOL.
Method of use
—
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence